Alto Neuroscience, Inc. ANRO
NYSE · United States · Health Technology
$24.24-1.07 (-4.23%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.65 | -0.73 | +11.5% | $0 | — | +12.2%$28.78→$32.30 |
| Q1 2026 | 2026-05-13 | -0.80 | -0.56 | -42.9% | — | — | -4.2%$24.63→$23.59 |
| Q4 2025 | 2026-03-16 | -0.45 | -0.51 | +11.8% | — | — | +0.4%$22.26→$22.36 |
| Q3 2025 | 2025-11-12 | -0.52 | -0.66 | +21.2% | — | — | -15.3%$13.40→$11.35 |
| Q4 2024 | 2025-03-20 | -0.52 | -0.65 | +20.0% | — | — | — |
| Q4 2023 | 2024-03-21 | -6.70 | -0.83 | -707.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.